Stockscreener 앱 받기
6.15
2.54%
-0.16
시간 외 거래:
6.10
-0.05
-0.81%
전일 마감가:
$6.31
열려 있는:
$6.31
하루 거래량:
626.18K
Relative Volume:
1.65
시가총액:
$115.39M
수익:
$109.43M
순이익/손실:
$5.13M
주가수익비율:
23.60
EPS:
0.2606
순현금흐름:
$18.91M
1주 성능:
+3.71%
1개월 성능:
-28.74%
6개월 성능:
-66.21%
1년 성능:
-28.57%
1일 변동 폭
$6.00
$6.49
1주일 범위
$5.96
$6.8236
52주 변동 폭
$5.54
$22.25
Optimizerx Corp Stock (OPRX) Company Profile
명칭
Optimizerx Corp
전화
248-651-6558
주소
260 CHARLES STREET, WALTHAM, MI
Compare OPRX vs VEEV, TEM, BTSG, HQY, MMED
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
OPRX
Optimizerx Corp
|
6.15 | 118.39M | 109.43M | 5.13M | 18.91M | 0.2606 |
|
VEEV
Veeva Systems Inc
|
185.59 | 30.25B | 3.20B | 908.91M | 1.42B | 5.4155 |
|
TEM
Tempus Ai Inc
|
48.74 | 8.70B | 1.27B | -245.03M | -245.36M | -1.4071 |
|
BTSG
Brightspring Health Services Inc
|
43.99 | 8.27B | 12.91B | 104.80M | 394.69M | 0.8769 |
|
HQY
Healthequity Inc
|
81.13 | 6.80B | 1.31B | 215.20M | 408.32M | 2.4627 |
|
MMED
Minimed Group Inc
|
17.11 | 4.71B | 0 | 0 | 0 | 0.00 |
Optimizerx Corp Stock (OPRX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-01-08 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
| 2024-12-20 | 개시 | Stephens | Equal-Weight |
| 2024-07-25 | 재개 | B. Riley Securities | Buy |
| 2024-04-04 | 개시 | JMP Securities | Mkt Outperform |
| 2024-01-03 | 개시 | Barclays | Equal Weight |
| 2023-02-02 | 재개 | B. Riley Securities | Buy |
| 2022-11-01 | 개시 | Stifel | Buy |
| 2022-07-15 | 개시 | SVB Leerink | Outperform |
| 2021-10-18 | 재개 | B. Riley Securities | Buy |
| 2021-04-13 | 개시 | RBC Capital Mkts | Outperform |
| 2019-01-03 | 개시 | William Blair | Outperform |
모두보기
Optimizerx Corp 주식(OPRX)의 최신 뉴스
Strength seen in OptimizeRx (OPRX): Can its 7.5% jump turn into more strength? - MSN
OptimizeRx Corp. (NASDAQ:OPRX) Short Interest Down 16.4% in February - MarketBeat
Is OptimizeRx (OPRX) Stock Undervalued Right Now? - Yahoo Finance
Best Value Stocks to Buy for March 16th - The Globe and Mail
Can OPRX's Patient Engagement Tools Win Amid Fierce Competition? - MSN
OptimizeRx Corp. (OPRX) Q4 earnings and revenues beat estimates - MSN
OptimizeRx (OPRX) outlines AI-driven pharma marketing strategy and key risks - Stock Titan
Should you sell your OptimizeRx stock? - Cantech Letter
OptimizeRx Corporation (NASDAQ:OPRX) Q4 2025 Earnings Call Transcript - Insider Monkey
Wall Street Analysts Are Bullish on Top Healthcare Picks - The Globe and Mail
OptimizeRx (OPRX) Q4 Profitability Turn Challenges Skeptical Earnings Narratives - simplywall.st
OptimizeRx (NASDAQ:OPRX) Price Target Cut to $20.00 by Analysts at Lake Street Capital - MarketBeat
OptimizeRx (NASDAQ:OPRX) Price Target Cut to $18.00 by Analysts at Roth Mkm - MarketBeat
OptimizeRx Warns Of Volatility From 'Most Favored Nation' Pricing Uncertainty - Bitget
Assessing OptimizeRx: Insights From 4 Financial Analysts - Benzinga
B. Riley Financial Reaffirms Buy Rating for OptimizeRx (NASDAQ:OPRX) - MarketBeat
OptimizeRx (OPRX) Target Price Lowered by Stephens & Co. | OPRX Stock News - GuruFocus
Stephens Cuts OptimizeRx (NASDAQ:OPRX) Price Target to $10.00 - MarketBeat
OptimizeRx (NASDAQ:OPRX) Announces Quarterly Earnings Results - MarketBeat
Stephens cuts OptimizeRx stock price target on soft pharma budgets - Investing.com Nigeria
OptimizeRx Corporation Q4 2025 Earnings Call Summary - Yahoo Finance
OptimizeRx (OPRX) Q4 2025 Earnings Call Transcript - AOL.com
Stephens cuts OptimizeRx stock price target on soft pharma budgets By Investing.com - Investing.com UK
OptimizeRx Reports Strong Fourth Quarter and Full Year 2025 Financial Results - The Manila Times
UPDATE – OptimizeRx Reports Strong Fourth Quarter and Full Year 2025 Financial Results - The Globe and Mail
OptimizeRx Corp (OPRX) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ... - Yahoo Finance
OptimizeRx Q4 Earnings Call Highlights - MarketBeat
Stock Repurchase Plan Initiated by OptimizeRx (NASDAQ:OPRX) Board of Directors - MarketBeat
From loss to profit: OptimizeRx posts record $109.4M sales and $10M buyback - Stock Titan
Earnings call transcript: OptimizeRx Q4 2025 earnings beat expectations amid cautious market - Investing.com
OptimizeRx Corp. (OPRX) Q4 Earnings and Revenues Beat Estimates - Yahoo Finance
OPTIMIZERx earnings beat by $0.29, revenue topped estimates - Investing.com Canada
UPDATEOptimizeRx Reports Strong Fourth Quarter and Full Year 2025 Financial Results - The Manila Times
Optimizerx Corp enters amendment no. 4 to financing agreementSEC filing - marketscreener.com
OptimizeRx Reports Strong Q4 2025 Results with Record Net Income and Adjusted EBITDA, Updates 2026 Revenue Guidance and Announces Share Repurchase Program - Quiver Quantitative
Optimizerx Corp Enters Amendment No. 4 To Financing Agreement- SEC Filing - TradingView
OptimizeRx Q4 Adjusted Earnings Rise; Reports Buyback Program - marketscreener.com
Geopolitics Watch: Can OptimizeRx Corporation sustain earnings growthTrade Performance Summary & Smart Money Movement Tracker - baoquankhu1.vn
OptimizeRx Corporation (OPRX) Stock Rises on Q4 2025 Earnings - Quiver Quantitative
OptimizeRx Authorizes $10 Million Share Repurchase Program - TipRanks
OptimizeRx (Nasdaq: OPRX) returns to profit and unveils $10M share repurchase plan - Stock Titan
OptimizeRx Corporation Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025 - marketscreener.com
OptimizeRx Sets Fourth Quarter and Full Year 2025 Financial Results Conference Call for March 5, 2026, at 4:30 P.m. ET - 富途牛牛
Earnings To Watch: OptimizeRx Corp (OPRX) Reports Q4 2025 Result - GuruFocus
OptimizeRx Corp. (NASDAQ:OPRX) Given Consensus Rating of "Moderate Buy" by Analysts - MarketBeat
OptimizeRx Corporation authorizes a Buyback Plan. - marketscreener.com
OptimizeRx Corp expected to post earnings of 23 cents a shareEarnings Preview - TradingView
OPRX Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Portfolio Update: Can OptimizeRx Corporation weather a recessionMarket Volume Summary & Pattern Based Trade Signal System - baoquankhu1.vn
OptimizeRx (OPRX) Projected to Post Quarterly Earnings on Thursday - MarketBeat
Can OptimizeRx Corporation sustain earnings growthQuarterly Trade Review & Breakout Confirmation Alerts - mfd.ru
Optimizerx Corp (OPRX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
5.94%
자본화:
|
볼륨(24시간):